Cite
Utilisation of Lacticaseibacillus casei ATCC 393‐derived exopolysaccharide for camel milk yoghurt production and its potential anticancer and hepatoprotective properties.
MLA
Ali, Mona S., et al. “Utilisation of Lacticaseibacillus Casei ATCC 393‐derived Exopolysaccharide for Camel Milk Yoghurt Production and Its Potential Anticancer and Hepatoprotective Properties.” International Journal of Dairy Technology, vol. 77, no. 3, Aug. 2024, pp. 792–803. EBSCOhost, https://doi.org/10.1111/1471-0307.13072.
APA
Ali, M. S., Darwish, A. A., Hassan, M. A., Hekal, S. A., E. Abdel, M. A., & Bakry, A. M. (2024). Utilisation of Lacticaseibacillus casei ATCC 393‐derived exopolysaccharide for camel milk yoghurt production and its potential anticancer and hepatoprotective properties. International Journal of Dairy Technology, 77(3), 792–803. https://doi.org/10.1111/1471-0307.13072
Chicago
Ali, Mona S., Aliaa A. Darwish, Mostafa A. Hassan, Sahar A. Hekal, Mobdy, Ahmed E. Abdel, and Amr M. Bakry. 2024. “Utilisation of Lacticaseibacillus Casei ATCC 393‐derived Exopolysaccharide for Camel Milk Yoghurt Production and Its Potential Anticancer and Hepatoprotective Properties.” International Journal of Dairy Technology 77 (3): 792–803. doi:10.1111/1471-0307.13072.